Publications
345 results found
Sultan S, Patel AG, El-Hassani S, et al., 2020, Male Obesity Associated Gonadal Dysfunction and the Role of Bariatric Surgery, FRONTIERS IN ENDOCRINOLOGY, Vol: 11, ISSN: 1664-2392
- Author Web Link
- Cite
- Citations: 16
Gomide Braga T, das Gracas Coelho de Souza M, Maranhao PA, et al., 2020, Evaluation of Heart Rate Variability and Endothelial Function 3 Months After Bariatric Surgery, OBESITY SURGERY, Vol: 30, Pages: 2450-2453, ISSN: 0960-8923
- Author Web Link
- Cite
- Citations: 6
le Roux CW, 2020, Biography: Carel le Roux, OBESITY SURGERY, Vol: 30, Pages: 2074-2075, ISSN: 0960-8923
- Author Web Link
- Cite
- Citations: 1
Neff KJ, Le Roux CW, 2020, The Effect of Metabolic Surgery on the Complications of Diabetes: What Are the Unanswered Questions?, FRONTIERS IN ENDOCRINOLOGY, Vol: 11, ISSN: 1664-2392
- Author Web Link
- Cite
- Citations: 5
Sudlow AC, Le Roux CW, Pournaras DJ, 2020, Long-term outcomes of bariatric surgery in patients with diabetes, EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, Vol: 15, Pages: 141-146, ISSN: 1744-6651
- Author Web Link
- Cite
- Citations: 3
Wilkinson M, Murphy S, Sinclair P, et al., 2020, Patient perceptions and understanding of obesity related endometrial cancer, GYNECOLOGIC ONCOLOGY REPORTS, Vol: 32, ISSN: 2352-5789
- Author Web Link
- Cite
- Citations: 6
Hyde KM, Blonde GD, Bueter M, et al., 2020, Gastric bypass in female rats lowers concentrated sugar solution intake an preference without affecting brief-access licking after long-term sugar exposure, AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, Vol: 318, Pages: R870-R885, ISSN: 0363-6119
- Author Web Link
- Cite
- Citations: 9
Rubino F, Puhl RM, Cummings DE, et al., 2020, Joint international consensus statement for ending stigma of obesity, NATURE MEDICINE, Vol: 26, Pages: 485-497, ISSN: 1078-8956
- Author Web Link
- Cite
- Citations: 339
Nielsen MS, Ritz C, Albrechtsen NJW, et al., 2020, Oxyntomodulin and Glicentin May Predict the Effect of Bariatric Surgery on Food Preferences and Weight Loss, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, Vol: 105, ISSN: 0021-972X
- Author Web Link
- Cite
- Citations: 35
McCrimmon RJ, Catarig A-M, Frias JP, et al., 2020, Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial, DIABETOLOGIA, Vol: 63, Pages: 473-485, ISSN: 0012-186X
- Author Web Link
- Cite
- Citations: 26
Sudlow A, le Roux CW, Pournaras DJ, 2020, The metabolic benefits of different bariatric operations: what procedure to choose?, ENDOCRINE CONNECTIONS, Vol: 9, Pages: R28-R35
- Author Web Link
- Cite
- Citations: 13
Martin WP, le Roux CW, 2020, Comment on: Impact of serum uric acid on renal function after bariatric surgery: a retrospective study comment, SURGERY FOR OBESITY AND RELATED DISEASES, Vol: 16, Pages: 295-298, ISSN: 1550-7289
- Author Web Link
- Cite
- Citations: 1
Nair M, Martin WP, Zhernovkov V, et al., 2020, Characterization of the renal cortical transcriptome following Roux-en-Y gastric bypass surgery in experimental diabetic kidney disease, BMJ OPEN DIABETES RESEARCH & CARE, Vol: 8
- Author Web Link
- Cite
- Citations: 7
Canney AL, Cohen R, Elliotti JA, et al., 2020, Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery, DIABETES & VASCULAR DISEASE RESEARCH, Vol: 17, ISSN: 1479-1641
- Author Web Link
- Cite
- Citations: 17
Grannell A, Al-Najim W, Mangan A, et al., 2019, Fat free mass is positively associated with hunger and energy intake at extremes of obesity, APPETITE, Vol: 143, ISSN: 0195-6663
- Author Web Link
- Cite
- Citations: 16
Sudlow AC, le Roux CW, Pournaras DJ, 2019, Review of Advances in Anti-obesity Pharmacotherapy: Implications for a Multimodal Treatment Approach with Metabolic Surgery, OBESITY SURGERY, Vol: 29, Pages: 4095-4104, ISSN: 0960-8923
- Author Web Link
- Cite
- Citations: 19
Friedman AN, Wang J, Wahed AS, et al., 2019, The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes, AMERICAN JOURNAL OF KIDNEY DISEASES, Vol: 74, Pages: 761-770, ISSN: 0272-6386
- Author Web Link
- Cite
- Citations: 15
Nielsen MS, Andersen INSK, Lange B, et al., 2019, Bariatric Surgery Leads to Short-Term Effects on Sweet Taste Sensitivity and Hedonic Evaluation of Fatty Food Stimuli, OBESITY, Vol: 27, Pages: 1796-1804, ISSN: 1930-7381
- Author Web Link
- Cite
- Citations: 24
Kokkinos A, Tsilingiris D, le Roux CW, et al., 2019, Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?, METABOLISM-CLINICAL AND EXPERIMENTAL, Vol: 100, ISSN: 0026-0495
- Author Web Link
- Cite
- Citations: 16
Lingvay I, Catarig A-M, Frias JP, et al., 2019, Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial, LANCET DIABETES & ENDOCRINOLOGY, Vol: 7, Pages: 834-844, ISSN: 2213-8587
- Author Web Link
- Cite
- Citations: 127
Holland JA, Martin WP, Docherty NG, et al., 2019, Impact of intentional weight loss on diabetic kidney disease, DIABETES OBESITY & METABOLISM, Vol: 21, Pages: 2338-2341, ISSN: 1462-8902
- Author Web Link
- Cite
- Citations: 7
Sudlow A, le Roux CW, Pournaras DJ, 2019, Review of multimodal treatment for type 2 diabetes: combining metabolic surgery and pharmacotherapy, THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, Vol: 10, ISSN: 2042-0188
- Author Web Link
- Cite
- Citations: 12
Mangan AM, Al Najim W, McNamara N, et al., 2019, Effect of Macronutrient Type and Gastrointestinal Release Site on PYY Response in Normal Healthy Subjects, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, Vol: 104, Pages: 3661-3669, ISSN: 0021-972X
- Author Web Link
- Cite
- Citations: 5
Nielsen MS, Schmidt JB, le Roux CW, et al., 2019, Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Food Preferences and Potential Mechanisms Involved, CURRENT OBESITY REPORTS, Vol: 8, Pages: 292-300, ISSN: 2162-4968
- Author Web Link
- Cite
- Citations: 18
Casella-Mariolo J, Castagneto-Gissey L, Angelini G, et al., 2019, Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device, EBIOMEDICINE, Vol: 46, Pages: 452-462, ISSN: 2352-3964
- Author Web Link
- Cite
- Citations: 6
Behary P, Tharakan G, Alexiadou K, et al., 2019, Combined GLP-1, oxyntomodulin, and peptide YY improves body weight and glycemia in obesity and prediabetes/type 2 diabetes: a randomized single-blinded placebo controlled study, Diabetes Care, Vol: 42, Pages: 1446-1453, ISSN: 0149-5992
OBJECTIVE: Roux-en-Y gastric bypass (RYGB) augments postprandial secretion of glucagon-like peptide 1 (GLP-1), oxyntomodulin (OXM), and peptide YY (PYY). Subcutaneous infusion of these hormones ("GOP"), mimicking postprandial levels, reduces energy intake. Our objective was to study the effects of GOP on glycemia and body weight when given for 4 weeks to patients with diabetes and obesity. RESEARCH DESIGN AND METHODS: In this single-blinded mechanistic study, obese patients with prediabetes/diabetes were randomized to GOP (n = 15) or saline (n = 11) infusion for 4 weeks. We also studied 21 patients who had undergone RYGB and 22 patients who followed a very low-calorie diet (VLCD) as unblinded comparators. Outcomes measured were 1) body weight, 2) fructosamine levels, 3) glucose and insulin during a mixed meal test (MMT), 4) energy expenditure (EE), 5) energy intake (EI), and 6) mean glucose and measures of glucose variability during continuous glucose monitoring. RESULTS: GOP infusion was well tolerated over the 4-week period. There was a greater weight loss (P = 0.025) with GOP (mean change -4.4 [95% CI -5.3, -3.5] kg) versus saline (-2.5 [-4.1, -0.9] kg). GOP led to a greater improvement (P = 0.0026) in fructosamine (-44.1 [-62.7, -25.5] µmol/L) versus saline (-11.7 [-18.9, -4.5] µmol/L). Despite a smaller weight loss compared with RYGB and VLCD, GOP led to superior glucose tolerance after a mixed-meal stimulus and reduced glycemic variability compared with RYGB and VLCD. CONCLUSIONS: GOP infusion improves glycemia and reduces body weight. It achieves superior glucose tolerance and reduced glucose variability compared with RYGB and VLCD. GOP is a viable alternative for the treatment of diabetes with favorable effects on body weight.
Dehestani B, le Roux CW, 2019, The Role of the Small Bowel in Unintentional Weight Loss after Treatment of Upper Gastrointestinal Cancers, JOURNAL OF CLINICAL MEDICINE, Vol: 8
- Author Web Link
- Cite
- Citations: 2
Suliman M, Buckley A, Al Tikriti A, et al., 2019, Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non-surgical and bariatric surgery patients, DIABETES OBESITY & METABOLISM, Vol: 21, Pages: 1498-1501, ISSN: 1462-8902
- Author Web Link
- Cite
- Citations: 43
Martin WP, le Roux CW, 2019, Comment on: Metabolic surgery improves renal injury independent of weight loss: a meta-analysis, SURGERY FOR OBESITY AND RELATED DISEASES, Vol: 15, Pages: 1020-1023, ISSN: 1550-7289
- Author Web Link
- Cite
- Citations: 7
Elliott JA, Docherty NG, Murphy CF, et al., 2019, Changes in gut hormones, glycaemic response and symptoms after oesophagectomy, BRITISH JOURNAL OF SURGERY, Vol: 106, Pages: 735-746, ISSN: 0007-1323
- Author Web Link
- Cite
- Citations: 10
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.